Juvenile Onset Huntington's Disease (JOHD) is a rare variant of HD withage of onset ≤20 years, accounting for 3–10% of all HD patients. The rarity occurrence of JOHD cases, who severely progress towards mental and physical disability with atypical clinical manifestations compared to classical HD, are responsible of general lack of knowledge about this variant. We obtained a fully reprogrammed iPS cell line from fibroblasts of a JOHD patient carrying 65 CAG repeats and age at onset at age 15. At the biopsy time, the patient showed an advanced stage after 10 years of disease.

Generation of the induced pluripotent stem cell line CSSi006-A (3681) from a patient affected by advanced-stage juvenile onset huntington's disease / Rotundo, G.; Bidollari, E.; Ferrari, D.; Spasari, I.; Bernardini, L.; Consoli, F.; De Luca, A.; Santimone, I.; Lamorte, G.; Migliore, S.; Squitieri, F.; Vescovi, A. L.; Rosati, J.. - In: STEM CELL RESEARCH. - ISSN 1873-5061. - 29:(2018), pp. 174-178. [10.1016/j.scr.2018.04.008]

Generation of the induced pluripotent stem cell line CSSi006-A (3681) from a patient affected by advanced-stage juvenile onset huntington's disease

Bidollari E.;Rosati J.
2018

Abstract

Juvenile Onset Huntington's Disease (JOHD) is a rare variant of HD withage of onset ≤20 years, accounting for 3–10% of all HD patients. The rarity occurrence of JOHD cases, who severely progress towards mental and physical disability with atypical clinical manifestations compared to classical HD, are responsible of general lack of knowledge about this variant. We obtained a fully reprogrammed iPS cell line from fibroblasts of a JOHD patient carrying 65 CAG repeats and age at onset at age 15. At the biopsy time, the patient showed an advanced stage after 10 years of disease.
2018
adult; cell line; female; humans; huntington disease; induced pluripotent stem cells; trinucleotide repeat expansion
01 Pubblicazione su rivista::01a Articolo in rivista
Generation of the induced pluripotent stem cell line CSSi006-A (3681) from a patient affected by advanced-stage juvenile onset huntington's disease / Rotundo, G.; Bidollari, E.; Ferrari, D.; Spasari, I.; Bernardini, L.; Consoli, F.; De Luca, A.; Santimone, I.; Lamorte, G.; Migliore, S.; Squitieri, F.; Vescovi, A. L.; Rosati, J.. - In: STEM CELL RESEARCH. - ISSN 1873-5061. - 29:(2018), pp. 174-178. [10.1016/j.scr.2018.04.008]
File allegati a questo prodotto
File Dimensione Formato  
Rotundo_Generation_2020.pdf

accesso aperto

Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Creative commons
Dimensione 882.09 kB
Formato Adobe PDF
882.09 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1340260
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact